Vfend and Blindness - a phase IV clinical study of FDA data

Summary:

Blindness is reported as a side effect among people who take Vfend (voriconazole), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Orgaran, and have Bronchopulmonary aspergillosis.

The phase IV clinical study analyzes which people have Blindness when taking Vfend. It is created by eHealthMe based on reports of 12,081 people who have side effects when taking Vfend from the FDA, and is updated regularly.

What is Vfend?

Vfend has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 12,128 Vfend users. Check the latest studies of Vfend.

What is Blindness?

Blindness is found to be associated with 1,507 drugs and 1,990 conditions by eHealthMe. Check the latest studies of Blindness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 15, 2026

12,081 people reported to have side effects when taking Vfend.
Among them, 70 people (0.58%) have Blindness.

Among these 70 people:

How long have people been on Vfend when they have Blindness? *

What is the gender of people who have Blindness when taking Vfend? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Blindness when taking Vfend? *

What are other drugs people take besides Vfend? *

What are other side effects people have besides Blindness? *

Vision Blurred: 17 people, 24.29%
Acute Kidney Failure: 12 people, 17.14%
Impaired Driving Ability: 12 people, 17.14%
Depression: 7 people, 10.00%
Dental Caries: 7 people, 10.00%
Visual Impairment: 6 people, 8.57%
Visual Acuity Reduced (reduced clearness of vision): 4 people, 5.71%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 4 people, 5.71%
Feeling Abnormal: 4 people, 5.71%
Intravascular Haemolysis (intravascular rupture of red blood cells with the release of haemoglobin and the cellular constituents into the plasma, or liquid portion of whole blood): 4 people, 5.71%

What are the existing conditions these people have? *

Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 8 people, 11.43%
Fungal Infection: 6 people, 8.57%
Systemic Candida (whole body fungal infection): 3 people, 4.29%
Leukaemia (blood or bone marrow cancer): 3 people, 4.29%
Infection: 3 people, 4.29%
Pulmonary Granuloma (tiny lump of inflamed tissue in the lungs): 2 people, 2.86%
Bronchopulmonary Aspergillosis Allergic (allergic lung disorder caused by aspergillus fungi): 2 people, 2.86%
Pneumonia: 2 people, 2.86%
Meningitis Fungal (fungal inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 2 people, 2.86%
Staphylococcal Infection (an infection with staphylococcus bacteria): 2 people, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Vfend and have Blindness?

- Check whether Blindness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vfend:

Vfend (12,128 reports)

Blindness treatments and more:

Blindness (45,948 reports)

Browse all side effects of Vfend:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blindness:

Blindness (1,507 drugs)

Browse all the conditions that are associated with Blindness:

Blindness (1,990 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on voriconazole (the active ingredients of Vfend) and Vfend (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.